Growth private equity firm TA Associates has promoted 10 staff members in the firm’s Boston, Menlo Park, Hong Kong and Mumbai offices, effective 1 January 2019. “We are delighted to announce these team members’ promotions, which were earned through their hard work and dedication to TA, our portfolio companies and

The Canadian Venture Capital and Private Equity Association (CVCA) has appointed Kim Furlong as its new Chief Executive Officer. After a decade in the corporate world, leading external affairs for Amgen Canada; a world-leading biotechnology company, Furlong brings an impressive network and a proven track record as a seasoned public

Law firm Collyer Bristow has added senior commercial real estate lawyer Simon Edwards to the firm’s 25-strong Real Estate practice. Edwards, who joined the firm on 2 January 2019 as a Partner, has had a career spanning 30 years in the London commercial real estate market, with particular expertise in

Stephen Moore, a former Rothschild and PwC dealmaker, is opening a Leeds office for Cavu Corporate Finance. He joins Shawn Bone, a prominent North East dealmaker who founded Cavu in Newcastle in 2013 and has established the independent advisory firm as a leading provider of expert corporate finance advice.  

Blank Rome has appointed Terrence A Everett as a Partner in the Firm’s Corporate, M&A, and Securities group in the Los Angeles office.  Everett, a seasoned transactional lawyer, focuses his practice on a range of corporate and finance transactions, mergers and acquisitions, corporate governance and securities, and real estate dealings.

Seward & Kissel has promoted Robert Gayda and Hoyoon Nam to partner. The firm has also promoted Daniel Bresler, Kimberly Giampietro, Andrei Sirabionian, Lori Sullivan, and Michael Weitman to counsel. The promotions were effective on 1 January, 2019. “This year’s promoted class is made up of a dynamic and enthusiastic

SV Health Investors, a venture capital and growth equity firm, has promoted Houman Ashrafian to Managing Partner and Greg Madden to Partner. SV manages seven funds that work to support entrepreneurs and companies that create breakthrough treatments and innovative healthcare solutions. The firm invests in early-stage opportunities in biotechnology; early-stage

GSK Stockmann has promoted four of its lawyers to partners – two Equity Partners and two Local Partners – effective 1 January 2019. The equity partners are Dr Jenny Mehlitz (Projects & Public Sector, Procurement, Berlin) and Andreas Dimmling (Restructuring/Insolvency, Corporate/M&A, Munich), while Associates Dr Jens Uwe Rügenhagen (Corporate/M&A, Dispute